Zhang Jingzhong, Hadlock Theresa, Gent Alison, Strichartz Gary R
Pain Research Center, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Biophys J. 2007 Jun 1;92(11):3988-4001. doi: 10.1529/biophysj.106.102434. Epub 2007 Mar 9.
Interactions of the local anesthetic tetracaine with unilamellar vesicles made of dimyristoyl or dipalmitoyl phosphatidylcholine (DMPC or DPPC), the latter without or with cholesterol, were examined by following changes in the drug's fluorescent properties. Tetracaine's location within the membrane (as indicated by the equivalent dielectric constant around the aromatic fluorophore), its membrane:buffer partition coefficients for protonated and base forms, and its apparent pK(a) when adsorbed to the membrane were determined by measuring, respectively, the saturating blue shifts of fluorescence emission at high lipid:tetracaine, the corresponding increases in fluorescence intensity at this lower wavelength with increasing lipid, and the dependence of fluorescence intensity of membrane-bound tetracaine (TTC) on solution pH. Results show that partition coefficients were greater for liquid-crystalline than solid-gel phase membranes, whether the phase was set by temperature or lipid composition, and were decreased by cholesterol; neutral TTC partitioned into membranes more strongly than the protonated species (TTCH(+)). Tetracaine's location in the membrane placed the drug's tertiary amine near the phosphate of the headgroup, its ester bond in the region of the lipids' ester bonds, and associated dipole field and the aromatic moiety near fatty acyl carbons 2-5; importantly, this location was unaffected by cholesterol and was the same for neutral and protonated tetracaine, showing that the dipole-dipole and hydrophobic interactions are the critical determinants of tetracaine's location. Tetracaine's effective pK(a) was reduced by 0.3-0.4 pH units from the solution pK(a) upon adsorption to these neutral bilayers, regardless of physical state or composition. We propose that the partitioning of tetracaine into solid-gel membranes is determined primarily by its steric accommodation between lipids, whereas in the liquid-crystalline membrane, in which the distance between lipid molecules is larger and steric hindrance is less important, hydrophobic and ionic interactions between tetracaine and lipid molecules predominate.
通过跟踪药物荧光特性的变化,研究了局部麻醉药丁卡因与由二肉豆蔻酰磷脂酰胆碱或二棕榈酰磷脂酰胆碱(DMPC或DPPC)制成的单层囊泡的相互作用,后者添加或未添加胆固醇。通过分别测量高脂质:丁卡因时荧光发射的饱和蓝移、在该较低波长下随着脂质增加荧光强度的相应增加以及膜结合丁卡因(TTC)的荧光强度对溶液pH的依赖性,确定了丁卡因在膜内的位置(由芳香族荧光团周围的等效介电常数表示)、其质子化形式和碱形式的膜:缓冲液分配系数以及吸附到膜上时的表观pK(a)。结果表明,无论相是由温度还是脂质组成设定,液晶相膜的分配系数都大于固体凝胶相膜,并且胆固醇会降低分配系数;中性TTC比质子化物种(TTCH(+))更强烈地分配到膜中。丁卡因在膜中的位置使药物的叔胺靠近头基团的磷酸,其酯键位于脂质酯键区域,相关偶极场和芳香部分靠近脂肪酰基碳2-5;重要的是,该位置不受胆固醇影响,对于中性和质子化丁卡因是相同的,表明偶极-偶极和疏水相互作用是丁卡因位置的关键决定因素。吸附到这些中性双层膜上后,丁卡因的有效pK(a)比溶液pK(a)降低了0.3-0.4个pH单位,无论其物理状态或组成如何。我们认为,丁卡因分配到固体凝胶膜中主要由其在脂质之间的空间容纳决定,而在液晶膜中,脂质分子之间的距离更大且空间位阻不太重要,丁卡因与脂质分子之间的疏水和离子相互作用占主导地位。